1. Cancer treatment-related decision-making among culturally and linguistically diverse older adults with cancer: A scoping review by the International Society of Geriatric Oncology Nursing and Allied Health Interest Group.
- Author
-
Leung B, Pilleron S, Bastiaannet E, Coombs LA, Jin R, Kantilal K, Kantilal K, Kenis C, Kobekyaa F, Kosmari L, Krok-Schoen JL, Li J, Mac Eochagain C, Newton L, Ruegg T, Stolz-Baskett P, Zhao Y, Bradley C, Puts M, and Haase KR
- Subjects
- Humans, United States, Aged, Canada, Public Opinion, Neoplasms therapy
- Abstract
Introduction: Countries with large economies are observing a growing number of culturally and linguistically diverse (CALD) older adults, many of whom will be affected by cancer. Little is known about the experiences and factors that influence cancer treatment decision-making in this population. The purposes of this scoping review are: (1) to summarize the published literature on cancer treatment-related decision-making with this population; and (2) to identify potential differences in how cancer treatment decisions are made compared to non-CALD older adults with cancer., Materials and Methods: We conducted a scoping review following Arksey and O'Malley and Levac methods, Preferred Reporting Items for Systematic Reviews and Meta-Analyses Scoping Review Guidelines. We conducted a comprehensive multidatabase search, screening 1,139 titles/abstracts. Following data abstraction, we analyzed the data using tabular and narrative summary., Results: We extracted data from six studies that met the inclusion criteria: four quantitative and two qualitative; five from the United States and one from Canada. Three themes were identified: (1) barriers to decision-making, (2) the influence of family and friends on decisionmaking, and (3) differences in uptake and types of treatment received between CALD and non-CALD older adults., Discussion: This comprehensive review of treatment decision-making among CALD older adults with cancer highlights the paucity of research in this area. The findings are limited to North American populations and may not represent experiences in other regions of the world. Future research should focus on studying their treatment-related decision-making experiences to improve the quality of care for this vulnerable population., Competing Interests: Declaration of Competing Interest BL has received honoraria from AstraZeneca outside of the submitted work. LAC has received payment for expert testimony, for travel to attend a meeting, and is an elected board of directors for the Advanced Practitioner Society for Hematology and Oncology (unpaid). LN and RJ are elected members of the board of directors for the Canadian Association of Nurses in Oncology (unpaid). CME, SP, KK, RJ, KK, PSB, JL, YZ, MP, CB, FK, JLK, TR, EB, CK, LK, and KRH have no disclosures., (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF